New study tracks Real-World relief for stubborn hand eczema
NCT ID NCT07603193
First seen Jun 05, 2026 · Last updated Jun 13, 2026 · Updated 2 times
Summary
This study follows 1000 adults with moderate to severe chronic hand eczema who are prescribed delgocitinib cream by their doctor. Researchers will track changes in skin symptoms and any side effects over 52 weeks to see how well the cream works in real-life settings. The goal is to understand if the treatment helps clear or nearly clear the eczema.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HAND ECZEMA (CHE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
LEO Pharma
Neu-Isenburg, Germany
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.